News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,770 Results
Type
Article (24608)
Company Profile (48)
Press Release (358113)
Multimedia
Podcasts (46)
Webinars (7)
Section
Business (111584)
Career Advice (1764)
Deals (22931)
Drug Delivery (84)
Drug Development (38365)
Employer Resources (65)
FDA (8010)
Job Trends (7706)
News (182305)
Policy (14009)
Tag
2027 Pharm Country Standard (1)
Academia (924)
Accelerated approval (22)
Adcomms (6)
Allergies (61)
Alliances (27389)
ALS (88)
Alzheimer's disease (609)
Antibody-drug conjugate (ADC) (160)
Approvals (8111)
Artificial intelligence (358)
Autoimmune disease (69)
Automation (24)
Bankruptcy (196)
Best Places to Work (5633)
BIOSECURE Act (15)
Biosimilars (96)
Biotechnology (42)
Bladder cancer (88)
Brain cancer (32)
Breast cancer (284)
Cancer (2571)
Cardiovascular disease (210)
Career advice (1400)
Career pathing (19)
CAR-T (150)
CDC (20)
Celiac Disease (1)
Cell therapy (448)
Cervical cancer (16)
Clinical research (33153)
Collaboration (1068)
Company closure (3)
Compensation (250)
Complete response letters (29)
COVID-19 (1238)
CRISPR (52)
C-suite (516)
Cystic fibrosis (71)
Data (3199)
Decentralized trials (1)
Denatured (13)
Depression (54)
Diabetes (228)
Diagnostics (3759)
Digital health (25)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (158)
Drug pricing (98)
Drug shortages (21)
Duchenne muscular dystrophy (134)
Earnings (50319)
Editorial (41)
Employer branding (10)
Employer resources (59)
Events (51626)
Executive appointments (583)
FDA (9630)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1105)
Gene editing (131)
Generative AI (30)
Gene therapy (393)
GLP-1 (505)
Government (1889)
Grass and pollen (2)
Guidances (323)
Healthcare (8601)
HIV (33)
Huntington's disease (25)
IgA nephropathy (37)
Immunology and inflammation (128)
Immuno-oncology (37)
Indications (47)
Infectious disease (1382)
Inflammatory bowel disease (95)
Inflation Reduction Act (8)
Influenza (63)
Intellectual property (142)
Interviews (310)
IPO (11020)
IRA (25)
Job creations (2206)
Job search strategy (1217)
JPM (44)
Kidney cancer (9)
Labor market (37)
Layoffs (227)
Leadership (22)
Legal (2946)
Liver cancer (51)
Longevity (7)
Lung cancer (360)
Lymphoma (185)
Machine learning (32)
Management (23)
Manufacturing (659)
MASH (97)
Medical device (6657)
Medtech (6681)
Mergers & acquisitions (12783)
Metabolic disorders (680)
Multiple sclerosis (71)
NASH (8)
Neurodegenerative disease (163)
Neuropsychiatric disorders (47)
Neuroscience (1197)
Neurotech (1)
NextGen: Class of 2026 (3200)
Non-profit (1288)
Now hiring (51)
Obesity (361)
Opinion (175)
Ovarian cancer (58)
Pain (83)
Pancreatic cancer (143)
Parkinson's disease (109)
Partnered (22)
Patents (221)
Patient recruitment (228)
Peanut (18)
People (30505)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (10895)
Phase 2 (14769)
Phase 3 (10899)
Pipeline (3434)
Policy (150)
Postmarket research (883)
Preclinical (4342)
Press Release (40)
Prostate cancer (108)
Psychedelics (26)
Radiopharmaceuticals (183)
Rare diseases (382)
Real estate (3790)
Recruiting (28)
Regulatory (11162)
Reports (29)
Research institute (991)
Resumes & cover letters (327)
Rett syndrome (12)
RNA editing (9)
RSV (34)
Schizophrenia (74)
Series A (210)
Series B (169)
Service/supplier (2)
Sickle cell disease (44)
Special edition (17)
Spinal muscular atrophy (51)
Sponsored (29)
Startups (2820)
State (2)
Stomach cancer (8)
Supply chain (75)
Tariffs (63)
The Weekly (32)
Vaccines (419)
Venture capital (90)
Weight loss (233)
Women's health (46)
Worklife (6)
Date
Today (13)
Last 7 days (276)
Last 30 days (1060)
Last 365 days (16573)
2026 (1540)
2025 (16851)
2024 (19215)
2023 (21292)
2022 (27784)
2021 (30329)
2020 (28566)
2019 (21365)
2018 (15789)
2017 (15692)
2016 (13320)
2015 (40731)
2014 (38854)
2013 (28122)
2012 (9115)
2011 (9711)
2010 (8172)
Location
Africa (576)
Alabama (43)
Alaska (3)
Arizona (114)
Arkansas (6)
Asia (25561)
Australia (3880)
California (6042)
Canada (1820)
China (616)
Colorado (277)
Connecticut (323)
Delaware (137)
Europe (54114)
Florida (941)
Georgia (164)
Hawaii (3)
Idaho (32)
Illinois (424)
India (41)
Indiana (252)
Iowa (10)
Japan (196)
Kansas (86)
Kentucky (9)
Louisiana (16)
Maine (48)
Maryland (600)
Massachusetts (4003)
Michigan (208)
Minnesota (310)
Mississippi (4)
Missouri (63)
Montana (9)
Nebraska (16)
Nevada (74)
New Hampshire (37)
New Jersey (1676)
New Mexico (20)
New York (1661)
North Carolina (836)
North Dakota (7)
Northern California (2878)
Ohio (189)
Oklahoma (11)
Oregon (15)
Pennsylvania (1158)
Puerto Rico (8)
Rhode Island (25)
South America (717)
South Carolina (50)
Southern California (2400)
Tennessee (76)
Texas (1042)
United States (21051)
Utah (132)
Vermont (1)
Virginia (154)
Washington D.C. (40)
Washington State (482)
West Virginia (3)
Wisconsin (62)
Wyoming (2)
382,770 Results for "check cap".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
Mergers & acquisitions
Pharmas Write Big M&A Checks Again as Patent Urgency Seizes C-Suites
2026 is set to be a banner year for M&A in biopharma, as buyers facing major patent cliffs fight for a small pool of late-stage assets.
December 17, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
January 8, 2026
·
5 min read
Press Releases
Vicore Pharma To Move To The Nasdaq Stockholm Mid Cap Segment
December 19, 2025
·
1 min read
Press Releases
Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
January 14, 2026
·
4 min read
Sponsored
After the JPM Hype, a Reality Check: Why your 2026 Strategy Hinges on your Manufacturing Toolkit
After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who accelerates timelines and anticipates every manufacturing hurdle. Learn how AGC Biologics offers tailored cell line solutions for complex molecules.
January 19, 2026
·
3 min read
Business
Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), today announced financial results and provided a corporate update for the third quarter and nine months ended September 30, 2023.
November 27, 2023
·
16 min read
Press Releases
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
January 20, 2026
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET
January 15, 2026
·
5 min read
Press Releases
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America’s Most Successful Small-Cap Companies
January 8, 2026
·
2 min read
1 of 38,277
Next
